Position in IMCR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,964,235
-$3,792,483 QoQ
Shares Held
187,850
-42.0% QoQ
Ownership
0.365%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 136 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in IMCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,847,277 across 523 Biotechnology names. IMCR ranks #161 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in IMCR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,964,235 | 187,850 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $9,756,718 | 323,606 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $9,966,106 | 287,125 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $9,780,179 | 269,204 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $7,464,640 | 237,879 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $5,158,454 | 173,861 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,853,907 | 130,641 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $12,602,200 | 404,825 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $29,445,797 | 868,864 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $52,082,810 | 801,274 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $62,653,741 | 917,063 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $49,880,465 | 961,088 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $48,724,812 | 812,622 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $39,378,513 | 796,491 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $20,243,983 | 354,722 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,029,263 | 149,750 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $871,075 | 23,347 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $70,324 | 2,352 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $48,107 | 1,405 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $86,038 | 2,321 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $781 | 20 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $647,361 | 15,207 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||